November 19, 2020 by Chain Drug Review
Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced the election of two new members to the CHPA Board of Directors during the association’s virtual November meeting. Newly elected CHPA board members include: Tim Grannan, president, Blistex Inc. Don Kerrigan, president, North America, The Nature’s Bounty Co. Kerrigan was also elected to serve on the
August 10, 2020 by Chain Drug Review
The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON – The Consumer Healthcare Products Association (CHPA) will hold its 2020 Regulatory, Scientific & Quality (RSQ) Conference virtually, for the first time ever, Tuesday, September 1, through Thursday, September 3. Using a dynamic virtual platform, attendees will hear distinguished speakers from the U.S. Food and Drug Administration (FDA), the U.S. Federal Trade Commission (FTC), U.S. Pharmacopeia (USP), academia, and industry.
July 9, 2020 by Chain Drug Review
current cannabidiol (CBD) marketplace, FDA, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement in response to the U.S. Food and Drug Administration (FDA) report to Congress on the current cannabidiol (CBD) marketplace: “While CHPA welcomes additional input from FDA regarding CBD, we’re concerned that the report conclusion further delays any action to better regulate CBD-containing products.
April 14, 2020 by Chain Drug Review
Paul Gama, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.
March 9, 2020 by Chain Drug Review
Dr. John Troup, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.
December 12, 2019 by Chain Drug Review
Dr. Stephen Hahn, FDA, Health and Human Services Secretary Alex Azar, The Consumer Healthcare Products Association (CHPA)
Leading Headlines

WASHINGTON — The United States Senate voted, 72-18, on Thursday to confirm Dr. Stephen Hahn as Commissioner of Food and Drugs. Health and Human Services Secretary Alex Azar issued the following statement: “I congratulate Dr. Hahn and thank the Senate for prioritizing his nomination. President Trump has chosen a superbly qualified leader for FDA, and
December 10, 2019 by Chain Drug Review
and Reform Act, Innovation, Scot Melville, The Consumer Healthcare Products Association (CHPA), the Over-the-Counter Drug Safety, U.S. Senate of S. 2740
Leading Headlines

WASHINGTON — The Consumer Healthcare Products Association (CHPA) applauds Tuesday’s passage in the U.S. Senate of S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a vote of 91-2. “Thanks to today’s decisive Senate action, our nation is one step closer to having a modern over-the-counter (O-T-C) regulatory framework that will better serve
December 4, 2019 by Chain Drug Review
Beth Allgaier, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior
November 14, 2019 by Chain Drug Review
CBD (cannabidiol), FDA, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
November 11, 2019 by Chain Drug Review
American Association of Colleges of Pharmacy (AACP), The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Pharmacy

WASHINGTON — The Consumer Healthcare Products Association (CHPA) and American Association of Colleges of Pharmacy (AACP) recently conducted a pilot effort to bolster pharmacy students’ training around over-the-counter (O-T-C) products. Through several CHPA member company donations,144 U.S. schools of pharmacy received over 100 different O-T-C medicines, medical devices, and dietary supplements to educate and prepare
July 22, 2019 by Chain Drug Review
CRN, Dietary Supplement Caucus, new label requirements for foods and dietary supplements, Paula Trumbo, the American Herbal Products Association (AHPA), The Consumer Healthcare Products Association (CHPA), The Council for Responsible Nutrition (CRN), the Natural Products Association (NPA), the United Natural Products Alliance (UNPA), U.S. Food and Drug Administration (FDA)
Leading Headlines

WASHINGTON — Due to changes in the American diet and updates in nutrition science, the U.S. Food and Drug Administration (FDA) mandated new label requirements for foods and dietary supplements. The label changes, ranging from measuring folic acid in micrograms of dietary folate equivalents (DFEs) to including added sugar and its percentage of daily value,
March 19, 2019 by Chain Drug Review
2019 Annual Executive Conference, Scott Melville, The Consumer Healthcare Products Association (CHPA)
Leading Headlines, Supplier News

WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning